Search research articles
Contact Us
Filters
Showing results (261-270 of 352) with videos related to
Page
of 36
Sort By:
Cancer Chemotherapy and Pharmacology
|
June 12, 2019
Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
Whitney P Kirschbrown, Bei Wang, Ihsan Nijem, et al.
Journal of the American Academy of Dermatology
|
June 5, 2019
Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials
Lourdes Maria Perez-Chada, Alice Bendix Gottlieb, Jeffrey Cohen, et al.
American Journal of Clinical Dermatology
|
January 18, 2020
Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative
Lourdes M Perez-Chada, Nicole F Salame, Adam R Ford, et al.
The British Journal of Dermatology
|
July 3, 2023
Healthcare experiences among patients with hidradenitis suppurativa: a qualitative study
Yacine Sow, Nicole Salame, Meron R Siira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2017
HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Manish A Shah, Rui-Hua Xu, Yung-Jue Bang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 12, 2024
Approved systemic drugs needed for dermatosis like alopecia areata, hidradenitis and vitiligo: A SPIN-FRT evaluation
Phyllis Spuls, Antonios Kolios, Marlide Jukema, et al.
Pigment Cell & Melanoma Research
|
April 21, 2025
Quality Analysis of Measurement Properties of Patient-Reported Outcome Measures for Vitiligo and of the Studies Assessing Them: A Systematic Review
Jolien Duponselle, Sandrine Herbelet, Liesbeth Delbaere, et al.
The Journal of Rheumatology
|
March 16, 2021
Pustular Psoriasis and Associated Musculoskeletal Disorders
Kristina Callis Duffin, Hervé Bachelez, Philip J Mease, et al.
JAAD International
|
January 31, 2022
Mucocutaneous manifestations among adults hospitalized with multisystem inflammatory syndrome following SARS-CoV-2 infection
Rachel Tannenbaum, Sergey Rekhtman, Andrew Strunk, et al.
British Journal of Clinical Pharmacology
|
January 17, 2012
Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
Rajesh Krishna, Daria Stypinski, Melissa Ali, et al.
Page
of 36
Search research articles
Search
Showing results (261-270 of 352) with videos related to
Sort By:
Page
of 36
Cancer Chemotherapy and Pharmacology
|
June 12, 2019
Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
Whitney P Kirschbrown, Bei Wang, Ihsan Nijem, et al.
Journal of the American Academy of Dermatology
|
June 5, 2019
Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials
Lourdes Maria Perez-Chada, Alice Bendix Gottlieb, Jeffrey Cohen, et al.
American Journal of Clinical Dermatology
|
January 18, 2020
Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative
Lourdes M Perez-Chada, Nicole F Salame, Adam R Ford, et al.
The British Journal of Dermatology
|
July 3, 2023
Healthcare experiences among patients with hidradenitis suppurativa: a qualitative study
Yacine Sow, Nicole Salame, Meron R Siira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2017
HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Manish A Shah, Rui-Hua Xu, Yung-Jue Bang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 12, 2024
Approved systemic drugs needed for dermatosis like alopecia areata, hidradenitis and vitiligo: A SPIN-FRT evaluation
Phyllis Spuls, Antonios Kolios, Marlide Jukema, et al.
Pigment Cell & Melanoma Research
|
April 21, 2025
Quality Analysis of Measurement Properties of Patient-Reported Outcome Measures for Vitiligo and of the Studies Assessing Them: A Systematic Review
Jolien Duponselle, Sandrine Herbelet, Liesbeth Delbaere, et al.
The Journal of Rheumatology
|
March 16, 2021
Pustular Psoriasis and Associated Musculoskeletal Disorders
Kristina Callis Duffin, Hervé Bachelez, Philip J Mease, et al.
JAAD International
|
January 31, 2022
Mucocutaneous manifestations among adults hospitalized with multisystem inflammatory syndrome following SARS-CoV-2 infection
Rachel Tannenbaum, Sergey Rekhtman, Andrew Strunk, et al.
British Journal of Clinical Pharmacology
|
January 17, 2012
Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
Rajesh Krishna, Daria Stypinski, Melissa Ali, et al.
Page
of 36